RANCHO CORDOVA, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) — iMD Companies, Inc. (OTC: ICBU) subsidiary Riize, LLC (Riize Health) — announces two new innovative products for the personal healthcare market. Riize Health will begin marketing Riize Hair, an advanced hair loss solution for men. With a proprietary formula, combining minoxidil, finasteride and biotin, the product […]

SAN JOSE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 3,000,000

LEHI, Utah, Oct. 15, 2024 (GLOBE NEWSWIRE) — Complete Solar Holdings, Inc. d/b/a Complete Solar (“Complete Solar” or the “Company”) (Nasdaq: CSLR), a solar technology, services, and installation company, today announced the appointment of Dan Myers to the position of Executive Vice President, New Homes Division, effective immediately. Mr. Myers will report to CEO, T.J.

Five Below has everything you need for a fun and affordable holiday season: decor, gifts, and stocking stuffers starting at just $1! Shop popular brands like Hello Kitty, Bluey, Stitch, Disney, Marvel, and Harry Potter, plus BIG DEAL Five Beyond gifts that kids will love PHILADELPHIA, Oct. 15, 2024 (GLOBE NEWSWIRE) — Five Below, Inc.

VANCOUVER, British Columbia, Oct. 15, 2024 (GLOBE NEWSWIRE) — Great Pacific Gold Corp. (“Great Pacific Gold,” “GPAC,” or the “Company”) (TSXV: GPAC) (OTCQX: FSXLF) (Germany: V3H) is providing an update on its Kesar Project (“Kesar” or the “Project”) located in the Eastern Highlands province of Papua New Guinea. The Kesar Project is contiguous with K92

SAN FRANCISCO, Oct. 15, 2024 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that new analyses of data from the Phase 2b ENLIVEN trial evaluating pegozafermin in patients with metabolic dysfunction-associated steatohepatitis (MASH)

LOS ANGELES, Oct. 15, 2024 (GLOBE NEWSWIRE) — via IBN – GolfLync, an innovative platform aimed at revolutionizing the golf experience, has re-engaged IBN, a multifaceted financial news and publishing firm for private and public entities, to support its corporate communications strategies as the company continues its expansion. In recent months, GolfLync has reached several

The W56 208-inch extended wheelbase model has completed the certification process for FMVSS and received HVIP certification for safety and environmental compliance. Full production of the W56 is underway at Workhorse’s Union City, Indiana facility, with deliveries expected in Q4 2024. With over 100 enhancements to the original step van model, the extended wheelbase W56

BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that it will host a KOL webinar focused on a nephrologist’s perspective on the

BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced the appointment of Dr. Amy Wechsler to its Board of Directors. Dr. Wechsler brings a unique combination of expertise and a proven track record of leadership in